美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=LEVOXYL"
符合检索条件的记录共12
2 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称LEVOXYL
申请号021301产品号001
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
2药品名称LEVOXYL
申请号021301产品号002
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
3药品名称LEVOXYL
申请号021301产品号003
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
4药品名称LEVOXYL
申请号021301产品号004
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
5药品名称LEVOXYL
申请号021301产品号005
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
6药品名称LEVOXYL
申请号021301产品号006
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
7药品名称LEVOXYL
申请号021301产品号007
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
8药品名称LEVOXYL
申请号021301产品号008
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
9药品名称LEVOXYL
申请号021301产品号009
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC
10药品名称LEVOXYL
申请号021301产品号010
活性成分LEVOTHYROXINE SODIUM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
治疗等效代码AB1,AB3参比药物
批准日期2001/05/25申请机构KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC